Surrozen, Inc. (SRZN)Healthcare | Biotechnology | South San Francisco, United States | NasdaqCM
23.39 USD
+0.02
(0.086%)
⇧
(June 12, 2026, 4 p.m.
EDT)
After hours: 23.39 |
Hot Take ↕ | June 7, 2026, 5:46 a.m. EDT
The immediate outlook is neutral-to-slightly-bearish as the stock trades at a discount to its moving averages, yet the overwhelming long-term picture is a severe value trap driven by a catastrophic multi-year decline. While the balance sheet currently shows a fortress-like liquidity position with massive cash reserves relative to debt, the business fundamentals are deteriorating rapidly, evidenced by negative operating margins, significant free cash flow burn, and a trailing twelve-month loss that renders the forward P/E meaningless. The price history confirms this structural failure, showing a nearly 94% drop over the last four years with the most recent annual performance also in the red. Although recent insider option grants and a 5.9% intraday surge suggest temporary speculative interest, these do not offset the reality that the company is burning cash without sustainable profitability. With no dividend history to speak of, investors are left with a high-risk biotech play that lacks the revenue growth or margin expansion required to justify its current valuation. |
| Model | MAE |
|---|---|
| MSTL_79 ✓ | 0.083464 |
| MSTL | 0.089038 |
| AutoETS | 0.089307 |
| AutoARIMA | 0.089308 |
| AutoTheta | 0.100133 |
| MSTL_79_105 | 0.102113 |
| MSTL_105 | 0.129392 |
Forecast horizon: 60 days | Selected: MSTL_79
| Forecast Reliability | |
|---|---|
| Score | 33% |
| H-stat | 2.32 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.442 |
| Excess Kurtosis | -0.14 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 0.805 |
| Market Cap | 271,566,560 |
| Forward P/E | -5.87 |
| Beta | 0.51 |
| Previous Name | Consonance-HFW Acquisition Corp. |
| Website | https://www.surrozen.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 1.451782 |
| Address1 | 171 Oyster Point Boulevard |
| Address2 | Suite 400 |
| All Time High | 210.0 |
| All Time Low | 4.5 |
| Ask | 29.69 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 90,100 |
| Average Daily Volume3 Month | 103,211 |
| Average Volume | 103,211 |
| Average Volume10Days | 90,100 |
| Beta | 0.506 |
| Bid | 17.14 |
| Bid Size | 2 |
| Book Value | -24.208 |
| City | South San Francisco |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 23.39 |
| Current Ratio | 11.913 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,780,012,800 |
| Day High | 25.13 |
| Day Low | 23.0001 |
| Display Name | Surrozen |
| Earnings Timestamp End | 1,746,821,116 |
| Earnings Timestamp Start | 1,746,821,116 |
| Ebitda | -42,689,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -4.016 |
| Enterprise To Revenue | 22.876 |
| Enterprise Value | 171,434,576 |
| Eps Current Year | -3.7 |
| Eps Forward | -3.985 |
| Eps Trailing Twelve Months | -36.59 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 28.1418 |
| Fifty Day Average Change | -4.7518005 |
| Fifty Day Average Change Percent | -0.16885205 |
| Fifty Two Week Change Percent | 145.17819 |
| Fifty Two Week High | 35.0 |
| Fifty Two Week High Change | -11.610001 |
| Fifty Two Week High Change Percent | -0.3317143 |
| Fifty Two Week Low | 8.0 |
| Fifty Two Week Low Change | 15.389999 |
| Fifty Two Week Low Change Percent | 1.9237499 |
| Fifty Two Week Range | 8.0 - 35.0 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,610,375,400,000 |
| Float Shares | 4,752,821 |
| Forward Eps | -3.985 |
| Forward P E | -5.8695107 |
| Free Cashflow | -26,107,124 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 44 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Gross Profits | -24,641,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.03176 |
| Held Percent Institutions | 1.01878 |
| Implied Shares Outstanding | 11,610,371 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,021-08-12 |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,702,512,000 |
| Last Split Factor | 1:15 |
| Long Business Summary | Surrozen, Inc., a biotechnology company, discovers and develops product candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the eye, intestine, liver, lung, retina, kidney, cochlea, cornea, skin, pancreas, and central nervous system. The company develops SZN-814, which combines Frizzled 4 (Fzd4 agonism) and vascular endothelial growth factor (VEGF antagonism) to treat diabetic macular edema (DME), neovascular age-related macular degeneration (wet AMD), and retinopathy indications; SZN-8143, which combines Fzd4 agonism, VEGF antagonism, and interleukin-6, or IL-6 for the treatment of DME/wet AMD/uveitic macular edema; and SZN-413, a Fzd4 targeted bi-specific antibody for the treatment of retinal vascular associated diseases. Surrozen, Inc. has a collaboration and license agreement with Boehringer Ingelheim International GmbH to research, develop, and commercialize Fzd4 bi-specific antibodies; and a research collaboration agreement with TCGFB, Inc. to discover antibody therapeutics targeting transforming growth factor beta, or TGF-ß, for the treatment of patients with idiopathic pulmonary fibrosis. Surrozen, Inc. was founded in 2015 and is headquartered in South San Francisco, California. |
| Long Name | Surrozen, Inc. |
| Market | us_market |
| Market Cap | 271,566,560 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_401948183 |
| Most Recent Quarter | 1,774,915,200 |
| Name Change Date | 2,026-06-12 |
| Net Income To Common | -342,560,992 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 271,392,422 |
| Number Of Analyst Opinions | 4 |
| Open | 23.67 |
| Operating Cashflow | -33,460,000 |
| Operating Margins | -2.0911999 |
| Payout Ratio | 0.0 |
| Phone | 650 489 9000 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 23.39 |
| Post Market Time | 1,781,294,410 |
| Prev Name | Consonance-HFW Acquisition Corp. |
| Previous Close | 23.37 |
| Price Eps Current Year | -6.3216214 |
| Price Hint | 2 |
| Price To Book | -0.9662095 |
| Price To Sales Trailing12 Months | 36.237865 |
| Profit Margins | 0.0 |
| Quick Ratio | 11.7 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0199986 |
| Regular Market Change Percent | 0.0855736 |
| Regular Market Day High | 25.13 |
| Regular Market Day Low | 23.0001 |
| Regular Market Day Range | 23.0001 - 25.13 |
| Regular Market Open | 23.67 |
| Regular Market Previous Close | 23.37 |
| Regular Market Price | 23.39 |
| Regular Market Time | 1,781,294,400 |
| Regular Market Volume | 71,099 |
| Return On Assets | -0.22819 |
| Revenue Growth | 4.086 |
| Revenue Per Share | 0.805 |
| Sand P52 Week Change | 0.23177934 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 11,610,371 |
| Shares Percent Shares Out | 0.0475 |
| Shares Short | 551,841 |
| Shares Short Previous Month Date | 1,777,507,200 |
| Shares Short Prior Month | 565,307 |
| Short Name | Surrozen, Inc. |
| Short Percent Of Float | 0.0864 |
| Short Ratio | 5.82 |
| Source Interval | 15 |
| State | CA |
| Symbol | SRZN |
| Target High Price | 44.0 |
| Target Low Price | 40.0 |
| Target Mean Price | 42.5 |
| Target Median Price | 43.0 |
| Total Cash | 106,910,000 |
| Total Cash Per Share | 9.208 |
| Total Debt | 6,778,000 |
| Total Revenue | 7,494,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -36.59 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 21.09443 |
| Two Hundred Day Average Change | 2.2955685 |
| Two Hundred Day Average Change Percent | 0.10882343 |
| Type Disp | Equity |
| Volume | 71,099 |
| Website | https://www.surrozen.com |
| Zip | 94,080 |